For the year ending 2025-12-31, PLSE made $350K in revenue. -$72,781K in net income. Net profit margin of -20794.57%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Product revenue | 350 | - | ||
| Cost of product revenue | 539 | - | ||
| Research and development | 44,721 | 32,336 | ||
| General and administrative | - | 23,921 | ||
| Selling, general and administrative | 32,029 | - | ||
| Total cost and expenses | 77,289 | 56,257 | ||
| Loss from operations | -76,939 | -56,257 | ||
| Interest income | 4,210 | 2,672 | ||
| Other expense | -52 | - | ||
| Total other income | 4,158 | 2,672 | ||
| Loss from operations, before income taxes | - | -53,585 | ||
| Net loss | -72,781 | -53,585 | ||
| Comprehensive loss | -72,781 | -53,585 | ||
| Net loss per share, basic and diluted (in dollars per share) | -1.08 | -0.92 | ||
| Weighted average common shares outstanding, basic and diluted (in shares) | 67,395,339 | 58,398,000 | ||
PULSE BIOSCIENCES, INC. (PLSE)
PULSE BIOSCIENCES, INC. (PLSE)